Adam Winstock
Adam Winstock
University College London
Verified email at globaldrugsurvey.com - Homepage
Title
Cited by
Cited by
Year
Mephedrone, new kid for the chop?
AR Winstock, LR Mitcheson, P Deluca, Z Davey, O Corazza, F Schifano
Addiction 106 (1), 154-161, 2011
3922011
Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK
AR Winstock, P Griffiths, D Stewart
Drug and alcohol dependence 64 (1), 9-17, 2001
3352001
Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample
AR Winstock, MJ Barratt
Drug and alcohol dependence 131 (1-2), 106-111, 2013
2872013
Mephedrone: use, subjective effects and health risks
A Winstock, L Mitcheson, J Ramsey, S Davies, M Puchnarewicz, ...
Addiction 106 (11), 1991-1996, 2011
2642011
Use of S ilk R oad, the online drug marketplace, in the United Kingdom, A ustralia and the United States
MJ Barratt, JA Ferris, AR Winstock
Addiction 109 (5), 774-783, 2014
2322014
Examining the profile of high-potency cannabis and its association with severity of cannabis dependence
TP Freeman, AR Winstock
Psychological medicine 45 (15), 3181-3189, 2015
2192015
Ketamine
K Wolff, AR Winstock
CNS drugs 20 (3), 199-218, 2006
2102006
The prevalence and natural history of urinary symptoms among recreational ketamine users
AR Winstock, L Mitcheson, DA Gillatt, AM Cottrell
BJU international 110 (11), 1762-1766, 2012
1732012
Safer scoring? Cryptomarkets, social supply and drug market violence
MJ Barratt, JA Ferris, AR Winstock
International Journal of Drug Policy 35, 24-31, 2016
1582016
Areca nut‐abuse liability, dependence and public health
A Winstock
Addiction biology 7 (1), 133-138, 2002
1582002
Ecstasy pill testing: harm minimization gone too far?
AR Winstock, K Wolff, J Ramsey
Addiction 96 (8), 1139-1148, 2001
1532001
Definitions related to the use of pharmaceutical opioids: Extramedical use, diversion, non‐adherence and aberrant medication‐related behaviours
B Larance, L Degenhardt, N Lintzeris, A Winstock, R Mattick
Drug and alcohol review 30 (3), 236-245, 2011
1322011
Mephedrone: still available and twice the price
A Winstock, L Mitcheson, J Marsden
The Lancet 376 (9752), 1537, 2010
1302010
Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population
K Wolff, EM Tsapakis, AR Winstock, D Hartley, D Holt, ML Forsling, ...
Journal of Psychopharmacology 20 (3), 400-410, 2006
1272006
Cannabis use in patients with multiple sclerosis
MS Chong, K Wolff, K Wise, C Tanton, A Winstock, E Silber
Multiple sclerosis journal 12 (5), 646-651, 2006
1232006
A dependency syndrome related to areca nut use: some medical and psychological aspects among areca nut users in the Gujarat community in the UK
AR Winstock, CR Trivedy, K Warnakulasuriya, TJ Peters
Addiction Biology 5 (2), 173-179, 2000
1232000
The NBOMe hallucinogenic drug series: patterns of use, characteristics of users and self-reported effects in a large international sample
W Lawn, M Barratt, M Williams, A Horne, A Winstock
Journal of Psychopharmacology 28 (8), 780-788, 2014
1212014
Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample
A Winstock, M Lynskey, R Borschmann, J Waldron
Journal of Psychopharmacology 29 (6), 698-703, 2015
1172015
5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users
J McCambridge, A Winstock, N Hunt, L Mitcheson
European addiction research 13 (1), 57-64, 2007
1172007
What should be done about mephedrone?
AR Winstock, J Marsden, L Mitcheson
Bmj 340, 2010
1142010
The system can't perform the operation now. Try again later.
Articles 1–20